patients were divided at random into three groups of 30 and treated 3-times daily over a period of 8 weeks with either 400 mg pentoxifylline ( 'trental ' 400 ) or 2 mg co-dergocrine mesylate , or remained untreated ( control group ) .
C0030899
pentoxifylline
C0699487
trental